Trends in net survival from 15 cancers in six European Latin countries: The SUDCAN population-based study material

E. Crocetti, N. Bossard, Z. Uhry, L. Roche, R. Capocaccia, Stefania Rossi, R. Capocaccia, J. Faivre, GRELL EUROCARE-5 Working Group, Roberta De Angelis, Massimiliano Caldora, E. Carrani, Silvia Giovanna Luisa Francisci, Sandra Mallone, Daniela Pierannunzio, Paolo Roazzi, Mariano Santaquilani, andrea tavilla

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

The aim of the SUDCAN collaborative study was to compare the net survival from 15 cancers diagnosed in 2000-2004 in six European Latin countries and provide trends in net survival and dynamics of excess mortality rates up to 5 years after diagnosis from 1992 to 2004 in France, Italy, Spain, and Switzerland, and from 2000 to 2004 in Belgium and Portugal. This paper presents a detailed description of the data analyzed and quality indicators. Incident cases from Belgium, France, Italy, Portugal, Spain, and Switzerland were retrieved from 56 general or specialized population-based cancer registries that participated in the EUROCARE-5 database. Fifteen cancer sites were analyzed. The data were checked according to the EUROCARE protocol. The percentages of excluded cases, cases based on death-certificate only, cases lost to follow-up at 5 years after diagnosis, and the proportions of microscopically verified cases were evaluated across countries and cancer sites. Data exclusions for major flaws were negligible. Cases based on death-certificate only were quite rare, except for some poor-prognosis cancers in some countries. The site-specific proportions of microscopically verified cases were generally high, but slightly lower in Italy than elsewhere. The percentage of cases lost to follow-up at 5 years after diagnosis was generally low. The net survival analyses in 2000-2004 included 873 314 tumors, whereas trend analyses included 1 426 004 tumors. The quality of the data analyzed was generally good. In fact, the analyzed data have been already checked and accepted for EUROCARE-5. However, slight differences in quality indexes, for some cancers, should be kept in mind in the interpretation of survival comparisons across countries. Copyright © 2017 Wolters Kluwer Health, Inc. All rights reserved.
Original languageEnglish
Pages (from-to)S3-S8
JournalEuropean Journal of Cancer Prevention
Volume26
Issue numberS3-S8
DOIs
Publication statusPublished - 2017

Fingerprint

Population
Neoplasms
Italy
Death Certificates
Portugal
Lost to Follow-Up
Belgium
Switzerland
Spain
France
Mortality
Survival Analysis
Registries
Databases
Health
Data Accuracy

Keywords

  • Cancer data collection
  • Cancer registries
  • Data collection
  • Europe
  • Net survival
  • Article
  • Belgium
  • breast cancer
  • cancer diagnosis
  • cancer localization
  • cancer mortality
  • cancer prognosis
  • cancer registry
  • cancer survival
  • clinical protocol
  • colon cancer
  • death certificate
  • esophagus cancer
  • European
  • follow up
  • France
  • head and neck cancer
  • human
  • Italy
  • kidney cancer
  • liver cancer
  • lung cancer
  • malignant neoplasm
  • melanoma
  • mortality rate
  • ovary cancer
  • pancreas cancer
  • Portugal
  • priority journal
  • prostate cancer
  • rectum cancer
  • Spain
  • stomach cancer
  • Switzerland
  • trend study
  • uterine cervix cancer
  • uterus cancer
  • clinical trial
  • epidemiology
  • factual database
  • health survey
  • mortality
  • multicenter study
  • neoplasm
  • procedures
  • survival analysis
  • survival rate
  • trends
  • Databases, Factual
  • Follow-Up Studies
  • Humans
  • Neoplasms
  • Population Surveillance
  • Survival Analysis
  • Survival Rate

Cite this

Trends in net survival from 15 cancers in six European Latin countries: The SUDCAN population-based study material. / Crocetti, E.; Bossard, N.; Uhry, Z.; Roche, L.; Capocaccia, R.; Rossi, Stefania; Capocaccia, R.; Faivre, J.; Group, GRELL EUROCARE-5 Working; De Angelis, Roberta; Caldora, Massimiliano; Carrani, E.; Francisci, Silvia Giovanna Luisa; Mallone, Sandra; Pierannunzio, Daniela; Roazzi, Paolo; Santaquilani, Mariano; tavilla, andrea.

In: European Journal of Cancer Prevention, Vol. 26, No. S3-S8, 2017, p. S3-S8.

Research output: Contribution to journalArticle

@article{536b2bf08fa64eafbde6e53eac88aacd,
title = "Trends in net survival from 15 cancers in six European Latin countries: The SUDCAN population-based study material",
abstract = "The aim of the SUDCAN collaborative study was to compare the net survival from 15 cancers diagnosed in 2000-2004 in six European Latin countries and provide trends in net survival and dynamics of excess mortality rates up to 5 years after diagnosis from 1992 to 2004 in France, Italy, Spain, and Switzerland, and from 2000 to 2004 in Belgium and Portugal. This paper presents a detailed description of the data analyzed and quality indicators. Incident cases from Belgium, France, Italy, Portugal, Spain, and Switzerland were retrieved from 56 general or specialized population-based cancer registries that participated in the EUROCARE-5 database. Fifteen cancer sites were analyzed. The data were checked according to the EUROCARE protocol. The percentages of excluded cases, cases based on death-certificate only, cases lost to follow-up at 5 years after diagnosis, and the proportions of microscopically verified cases were evaluated across countries and cancer sites. Data exclusions for major flaws were negligible. Cases based on death-certificate only were quite rare, except for some poor-prognosis cancers in some countries. The site-specific proportions of microscopically verified cases were generally high, but slightly lower in Italy than elsewhere. The percentage of cases lost to follow-up at 5 years after diagnosis was generally low. The net survival analyses in 2000-2004 included 873 314 tumors, whereas trend analyses included 1 426 004 tumors. The quality of the data analyzed was generally good. In fact, the analyzed data have been already checked and accepted for EUROCARE-5. However, slight differences in quality indexes, for some cancers, should be kept in mind in the interpretation of survival comparisons across countries. Copyright {\circledC} 2017 Wolters Kluwer Health, Inc. All rights reserved.",
keywords = "Cancer data collection, Cancer registries, Data collection, Europe, Net survival, Article, Belgium, breast cancer, cancer diagnosis, cancer localization, cancer mortality, cancer prognosis, cancer registry, cancer survival, clinical protocol, colon cancer, death certificate, esophagus cancer, European, follow up, France, head and neck cancer, human, Italy, kidney cancer, liver cancer, lung cancer, malignant neoplasm, melanoma, mortality rate, ovary cancer, pancreas cancer, Portugal, priority journal, prostate cancer, rectum cancer, Spain, stomach cancer, Switzerland, trend study, uterine cervix cancer, uterus cancer, clinical trial, epidemiology, factual database, health survey, mortality, multicenter study, neoplasm, procedures, survival analysis, survival rate, trends, Databases, Factual, Follow-Up Studies, Humans, Neoplasms, Population Surveillance, Survival Analysis, Survival Rate",
author = "E. Crocetti and N. Bossard and Z. Uhry and L. Roche and R. Capocaccia and Stefania Rossi and R. Capocaccia and J. Faivre and Group, {GRELL EUROCARE-5 Working} and {De Angelis}, Roberta and Massimiliano Caldora and E. Carrani and Francisci, {Silvia Giovanna Luisa} and Sandra Mallone and Daniela Pierannunzio and Paolo Roazzi and Mariano Santaquilani and andrea tavilla",
note = "Cited By :15 Export Date: 10 April 2018 CODEN: EJUPE Correspondence Address: Crocetti, E.; Romagna Cancer Registry, Romagna Cancer Institute (IRST), IRCCS, via Piero Maroncelli, 40, Italy; email: emanuelecrocetti@yahoo.com Funding details: 20102202 Funding details: Compagnia di San Paolo Funding details: EC, European Commission Funding details: Ligue Contre le Cancer Funding details: Fondazione Cariplo Funding details: RF-2009-1529710 Funding text: The SUDCAN study was supported by the French Ligue contre le Cancer. The EUROCARE study was supported by The Compagnia di San Paolo, Fondazione Cariplo, the Italian Ministry of Health (Ricerca Finalizzata 2009, RF-2009-1529710) and the European Commission (European Action Against Cancer, EPAAC, Joint Action No. 20102202). References: Allemani, C., Storm, H., Voogd, A.C., Holli, K., Izarzugaza, I., Torrella-Ramos, A., Variation in 'standard care' for breast cancer across Europe: A EUROCARE-3 high resolution study (2010) Eur J Cancer, 46, pp. 1528-1536; Baili, P., Micheli, A., Montanari, A., Capocaccia, R., Comparison of four methods for estimating complete life tables from abridged life tables using mortality data supplied to EUROCARE-3 (2005) Math Popul Stud, 12, pp. 183-198; Brenner, H., Castro, F.A., Eberle, A., Emrich, K., Holleczek, B., Katalinic, A., Jansen, L., Death certificate only proportions should be age adjusted in studies comparing cancer survival across populations and over time (2016) Eur J Cancer, 52, pp. 102-108; Curado, M.P., Okamoto, N., Ries, L., Sriplung, H., Young, J., Carli, P.M., (2004) International Rules for Multiple Primary Cancers (ICD-O Third Edition) Internal Report No 2004/02, , http://www.encr.eu/images/docs/recommendations/MPrules_july2004.pdf, Lyon, France: International Agency for Research on Cancer. [Accessed 1 February 2016]; De Angelis, R., Francisci, S., Baili, P., Marchesi, F., Roazzi, P., Belot, A., The EUROCARE-4 database on cancer survival in Europe: Data standardisation, quality control and methods of statistical analysis (2009) Eur J Cancer, 45, pp. 909-930; De Angelis, R., Sant, M., Coleman, M.P., Francisci, S., Baili, P., Pierannunzio, D., Cancer survival in Europe 1999-2007 by country and age: Results of EUROCARE-5 - A population-based study (2014) Lancet Oncol, 15, pp. 23-34; Forman, D., Bray, F., Brewster, D.H., Gombe Mbalawa, C., Kohler, B., Pi{\~n}eros, M., (2013) Cancer Incidence in Five Continents, 10. , http://ci5.iarc.fr, (electronic version). Lyon, France: International Agency for Research on Cancer. [Accessed 27 January 2016]; (2014) Human Mortality Database, , http://www.mortality.org, University of California, Berkeley (USA), and Max Planck Institute for Demographic Research (Germany). [Accessed 1 February 2016]; Lepage, C., Capocaccia, R., Hackl, M., Lemmens, V., Molina, E., Pierannunzio, D., Survival in patients with primary liver cancer, gallbladder and extrahepatic biliary tract cancer and pancreatic cancer in Europe 1999-2007: Results of EUROCARE-5 (2015) Eur J Cancer, , [Epub ahead of print]; Marcos-Gragera, R., Mallone, S., Kiemeney, L.A., Vilardell, L., Malats, N., Allory, Y., Urinary tract cancer survival in Europe 1999-2007: Results of the population-based study EUROCARE-5 (2015) Eur J Cancer, , [Epub ahead of print]; Rossi, S., Baili, P., Capocaccia, R., Caldora, M., Carrani, E., Minicozzi, P., The EUROCARE-5 study on cancer survival in Europe 1999-2007: Database, quality checks and statistical analysis methods (2015) Eur J Cancer, 51, pp. 2104-2119; Silcocks, P., Survival of death certificate initiated registrations: Selection bias, incomplete trace-back or higher mortality? (2006) Br J Cancer, 95, pp. 1576-1578; Uhry, Z., Bossard, N., Remontet, L., Iwaz, J., Roche, L., New insights into survival trend analyses in cancer population-based studies: The SUDCAN methodology (2016) Eur J Cancer Prev, 25, pp. S9-S15",
year = "2017",
doi = "10.1097/CEJ.0000000000000300",
language = "English",
volume = "26",
pages = "S3--S8",
journal = "European Journal of Cancer Prevention",
issn = "0959-8278",
publisher = "Lippincott Williams and Wilkins",
number = "S3-S8",

}

TY - JOUR

T1 - Trends in net survival from 15 cancers in six European Latin countries: The SUDCAN population-based study material

AU - Crocetti, E.

AU - Bossard, N.

AU - Uhry, Z.

AU - Roche, L.

AU - Capocaccia, R.

AU - Rossi, Stefania

AU - Capocaccia, R.

AU - Faivre, J.

AU - Group, GRELL EUROCARE-5 Working

AU - De Angelis, Roberta

AU - Caldora, Massimiliano

AU - Carrani, E.

AU - Francisci, Silvia Giovanna Luisa

AU - Mallone, Sandra

AU - Pierannunzio, Daniela

AU - Roazzi, Paolo

AU - Santaquilani, Mariano

AU - tavilla, andrea

N1 - Cited By :15 Export Date: 10 April 2018 CODEN: EJUPE Correspondence Address: Crocetti, E.; Romagna Cancer Registry, Romagna Cancer Institute (IRST), IRCCS, via Piero Maroncelli, 40, Italy; email: emanuelecrocetti@yahoo.com Funding details: 20102202 Funding details: Compagnia di San Paolo Funding details: EC, European Commission Funding details: Ligue Contre le Cancer Funding details: Fondazione Cariplo Funding details: RF-2009-1529710 Funding text: The SUDCAN study was supported by the French Ligue contre le Cancer. The EUROCARE study was supported by The Compagnia di San Paolo, Fondazione Cariplo, the Italian Ministry of Health (Ricerca Finalizzata 2009, RF-2009-1529710) and the European Commission (European Action Against Cancer, EPAAC, Joint Action No. 20102202). References: Allemani, C., Storm, H., Voogd, A.C., Holli, K., Izarzugaza, I., Torrella-Ramos, A., Variation in 'standard care' for breast cancer across Europe: A EUROCARE-3 high resolution study (2010) Eur J Cancer, 46, pp. 1528-1536; Baili, P., Micheli, A., Montanari, A., Capocaccia, R., Comparison of four methods for estimating complete life tables from abridged life tables using mortality data supplied to EUROCARE-3 (2005) Math Popul Stud, 12, pp. 183-198; Brenner, H., Castro, F.A., Eberle, A., Emrich, K., Holleczek, B., Katalinic, A., Jansen, L., Death certificate only proportions should be age adjusted in studies comparing cancer survival across populations and over time (2016) Eur J Cancer, 52, pp. 102-108; Curado, M.P., Okamoto, N., Ries, L., Sriplung, H., Young, J., Carli, P.M., (2004) International Rules for Multiple Primary Cancers (ICD-O Third Edition) Internal Report No 2004/02, , http://www.encr.eu/images/docs/recommendations/MPrules_july2004.pdf, Lyon, France: International Agency for Research on Cancer. [Accessed 1 February 2016]; De Angelis, R., Francisci, S., Baili, P., Marchesi, F., Roazzi, P., Belot, A., The EUROCARE-4 database on cancer survival in Europe: Data standardisation, quality control and methods of statistical analysis (2009) Eur J Cancer, 45, pp. 909-930; De Angelis, R., Sant, M., Coleman, M.P., Francisci, S., Baili, P., Pierannunzio, D., Cancer survival in Europe 1999-2007 by country and age: Results of EUROCARE-5 - A population-based study (2014) Lancet Oncol, 15, pp. 23-34; Forman, D., Bray, F., Brewster, D.H., Gombe Mbalawa, C., Kohler, B., Piñeros, M., (2013) Cancer Incidence in Five Continents, 10. , http://ci5.iarc.fr, (electronic version). Lyon, France: International Agency for Research on Cancer. [Accessed 27 January 2016]; (2014) Human Mortality Database, , http://www.mortality.org, University of California, Berkeley (USA), and Max Planck Institute for Demographic Research (Germany). [Accessed 1 February 2016]; Lepage, C., Capocaccia, R., Hackl, M., Lemmens, V., Molina, E., Pierannunzio, D., Survival in patients with primary liver cancer, gallbladder and extrahepatic biliary tract cancer and pancreatic cancer in Europe 1999-2007: Results of EUROCARE-5 (2015) Eur J Cancer, , [Epub ahead of print]; Marcos-Gragera, R., Mallone, S., Kiemeney, L.A., Vilardell, L., Malats, N., Allory, Y., Urinary tract cancer survival in Europe 1999-2007: Results of the population-based study EUROCARE-5 (2015) Eur J Cancer, , [Epub ahead of print]; Rossi, S., Baili, P., Capocaccia, R., Caldora, M., Carrani, E., Minicozzi, P., The EUROCARE-5 study on cancer survival in Europe 1999-2007: Database, quality checks and statistical analysis methods (2015) Eur J Cancer, 51, pp. 2104-2119; Silcocks, P., Survival of death certificate initiated registrations: Selection bias, incomplete trace-back or higher mortality? (2006) Br J Cancer, 95, pp. 1576-1578; Uhry, Z., Bossard, N., Remontet, L., Iwaz, J., Roche, L., New insights into survival trend analyses in cancer population-based studies: The SUDCAN methodology (2016) Eur J Cancer Prev, 25, pp. S9-S15

PY - 2017

Y1 - 2017

N2 - The aim of the SUDCAN collaborative study was to compare the net survival from 15 cancers diagnosed in 2000-2004 in six European Latin countries and provide trends in net survival and dynamics of excess mortality rates up to 5 years after diagnosis from 1992 to 2004 in France, Italy, Spain, and Switzerland, and from 2000 to 2004 in Belgium and Portugal. This paper presents a detailed description of the data analyzed and quality indicators. Incident cases from Belgium, France, Italy, Portugal, Spain, and Switzerland were retrieved from 56 general or specialized population-based cancer registries that participated in the EUROCARE-5 database. Fifteen cancer sites were analyzed. The data were checked according to the EUROCARE protocol. The percentages of excluded cases, cases based on death-certificate only, cases lost to follow-up at 5 years after diagnosis, and the proportions of microscopically verified cases were evaluated across countries and cancer sites. Data exclusions for major flaws were negligible. Cases based on death-certificate only were quite rare, except for some poor-prognosis cancers in some countries. The site-specific proportions of microscopically verified cases were generally high, but slightly lower in Italy than elsewhere. The percentage of cases lost to follow-up at 5 years after diagnosis was generally low. The net survival analyses in 2000-2004 included 873 314 tumors, whereas trend analyses included 1 426 004 tumors. The quality of the data analyzed was generally good. In fact, the analyzed data have been already checked and accepted for EUROCARE-5. However, slight differences in quality indexes, for some cancers, should be kept in mind in the interpretation of survival comparisons across countries. Copyright © 2017 Wolters Kluwer Health, Inc. All rights reserved.

AB - The aim of the SUDCAN collaborative study was to compare the net survival from 15 cancers diagnosed in 2000-2004 in six European Latin countries and provide trends in net survival and dynamics of excess mortality rates up to 5 years after diagnosis from 1992 to 2004 in France, Italy, Spain, and Switzerland, and from 2000 to 2004 in Belgium and Portugal. This paper presents a detailed description of the data analyzed and quality indicators. Incident cases from Belgium, France, Italy, Portugal, Spain, and Switzerland were retrieved from 56 general or specialized population-based cancer registries that participated in the EUROCARE-5 database. Fifteen cancer sites were analyzed. The data were checked according to the EUROCARE protocol. The percentages of excluded cases, cases based on death-certificate only, cases lost to follow-up at 5 years after diagnosis, and the proportions of microscopically verified cases were evaluated across countries and cancer sites. Data exclusions for major flaws were negligible. Cases based on death-certificate only were quite rare, except for some poor-prognosis cancers in some countries. The site-specific proportions of microscopically verified cases were generally high, but slightly lower in Italy than elsewhere. The percentage of cases lost to follow-up at 5 years after diagnosis was generally low. The net survival analyses in 2000-2004 included 873 314 tumors, whereas trend analyses included 1 426 004 tumors. The quality of the data analyzed was generally good. In fact, the analyzed data have been already checked and accepted for EUROCARE-5. However, slight differences in quality indexes, for some cancers, should be kept in mind in the interpretation of survival comparisons across countries. Copyright © 2017 Wolters Kluwer Health, Inc. All rights reserved.

KW - Cancer data collection

KW - Cancer registries

KW - Data collection

KW - Europe

KW - Net survival

KW - Article

KW - Belgium

KW - breast cancer

KW - cancer diagnosis

KW - cancer localization

KW - cancer mortality

KW - cancer prognosis

KW - cancer registry

KW - cancer survival

KW - clinical protocol

KW - colon cancer

KW - death certificate

KW - esophagus cancer

KW - European

KW - follow up

KW - France

KW - head and neck cancer

KW - human

KW - Italy

KW - kidney cancer

KW - liver cancer

KW - lung cancer

KW - malignant neoplasm

KW - melanoma

KW - mortality rate

KW - ovary cancer

KW - pancreas cancer

KW - Portugal

KW - priority journal

KW - prostate cancer

KW - rectum cancer

KW - Spain

KW - stomach cancer

KW - Switzerland

KW - trend study

KW - uterine cervix cancer

KW - uterus cancer

KW - clinical trial

KW - epidemiology

KW - factual database

KW - health survey

KW - mortality

KW - multicenter study

KW - neoplasm

KW - procedures

KW - survival analysis

KW - survival rate

KW - trends

KW - Databases, Factual

KW - Follow-Up Studies

KW - Humans

KW - Neoplasms

KW - Population Surveillance

KW - Survival Analysis

KW - Survival Rate

U2 - 10.1097/CEJ.0000000000000300

DO - 10.1097/CEJ.0000000000000300

M3 - Article

VL - 26

SP - S3-S8

JO - European Journal of Cancer Prevention

JF - European Journal of Cancer Prevention

SN - 0959-8278

IS - S3-S8

ER -